Breaking News, Collaborations & Alliances

SHL Medical, MoonLake Immunotherapeutics Partner on Sonelokimab Autoinjector

SHL Medical will provide device development expertise, assembly guidance, and production competencies to support the sonelokimab drug-device project.

SHL Medical, a provider of advanced drug delivery solutions, signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake’s Nanobody sonelokimab based on SHL Medical’s Molly autoinjector technology. Under the agreement, SHL Medical will provide its device development expertise, assembly guidance, and produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters